ABEO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Abeona Therapeutics Inc (ABEO) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The technical indicators are bearish, the financial performance is weak, and there are no significant positive catalysts or trading signals to support a buy decision. Holding off for now is recommended.
The technical indicators for ABEO are bearish. The MACD histogram is negative and expanding downward (-0.0319), the RSI is at 27.871 (neutral but close to oversold), and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with S1 at 4.847 and S2 at 4.655, indicating further downside potential.
No significant positive catalysts identified. There is no recent news, and hedge fund and insider trading activity are neutral.
The stock has shown a consistent decline in price (-2.01% during regular market hours, -1.70% post-market). The financial performance is poor, with significant YoY declines in net income (-82.95%) and EPS (-84.13%). Technical indicators are bearish, and there is no recent congress trading data or analyst upgrades to support a positive outlook.
In Q3 2025, revenue remained at 0 with no YoY growth. Net income dropped significantly to -$5.16M (-82.95% YoY), and EPS fell to -0.1 (-84.13% YoY). Gross margin remained negative at -22, showing no improvement. Overall, the financial performance indicates weak fundamentals.
No recent analyst ratings or price target changes are available. There is no Wall Street sentiment to support a buy decision.
